-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: What are the advantages of SCID mouse NK drug efficacy model?
Author:
InnoModels
Release time:
2024-03-18
With the rapid development of the biomedical field, the demand for new drug development has become increasingly urgent. In this context, the SCID mouse NK pharmacodynamic model of InnoModels Biotechnology has become an indispensable tool for new drug discovery and development by virtue of its unique advantages. In this paper, we will introduce the characteristics of the SCID mouse NK pharmacodynamic model and its application value in drug discovery and development.
Overview of the SCID mouse NK pharmacodynamic model
SCID mice (severe combined immunodeficiency mice) are an animal model of innate immune system defects with extremely low T and B cell immunity. And NK cells (natural killer cells), as an important part of the immune system, have a variety of functions such as antiviral, anti-tumor and immunomodulation. Combining SCID mice with NK cells to construct the SCID mouse NK drug efficacy model can mimic the response of the human immune system in specific disease states and provide powerful support for new drug development.
Advantages of SCID Mouse NK Efficacy Model
1. Highly simulate the human immune system: The SCID mouse NK efficacy model can simulate the response of the human immune system in specific disease states, providing a test environment closer to the actual one for new drug development. This helps researchers to identify potential safety risks at the early stage of new drug development and improve the success rate of drug development.
2. High sensitivity: Due to the defective immune system of SCID mice, NK cells play a crucial role in the evaluation of new drug efficacy. Therefore, the SCID mouse NK efficacy model has high sensitivity in the assessment of new drug efficacy, which helps to discover drugs with potential efficacy.
3. Reproducibility: The SCID mouse NK pharmacodynamic model has a stable genetic background and controllable experimental conditions, which makes the experimental results highly reproducible. This facilitates data accumulation and comparative analysis in the process of new drug development.
4. Wide application: The SCID mouse NK efficacy model can be used to evaluate the efficacy of many types of drugs, such as antiviral drugs, antitumor drugs and immunomodulatory drugs. This makes the model has a wide range of applications in the field of new drug development.

Application of SCID mouse NK efficacy model in new drug development
1. Drug screening: Using the SCID mouse NK pharmacodynamic model, researchers can quickly screen a large number of drug candidates and discover drugs with potential efficacy. This helps to shorten the cycle of new drug development and reduce R&D costs.
2. Drug efficacy evaluation: The SCID mouse NK efficacy model can be used to evaluate the efficacy of new drugs in different disease states, providing powerful support for drug development. By comparing the efficacy of different drugs in different disease states, researchers can select the most promising drugs for in-depth study.
3. Drug action mechanism research: SCID mouse NK efficacy model can also be used to study the mechanism of action of new drugs. By observing the changes in the efficacy of new drugs in the model, researchers can gain an in-depth understanding of the interaction between drugs and the immune system, providing a theoretical basis for drug development.
Summary
With its advantages of highly simulating the human immune system, high sensitivity, reproducibility and wide application, the SCID mouse NK efficacy model of InnoModels Biotechnology has become an important tool in the field of new drug research and development. By utilizing this model, researchers can quickly screen out drugs with potential therapeutic effects, assess drug efficacy, and study drug action mechanisms in depth, providing powerful support for the development and application of new drugs. With the continuous development of the biomedical field, the SCID mouse NK efficacy model will play an even more important role in the future development of new drugs.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd